Association of liver enzymes with metabolic syndrome and carotid atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study

References

• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;12:1595–607.
   Google Scholar
• Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, . The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;21:2709–16.
   Google Scholar
• Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, . Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;4:403–14.
   Google Scholar
• Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;1:27–38.
   Google Scholar
• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;16:1221–31.
   Google Scholar
• Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology. 2005;1:375–8.
   Google Scholar
• Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem. 2007;4: 686–92.
   Google Scholar
• Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;4:459–67.
   Google Scholar
• Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol. 2008;4:600–7.
   Google Scholar
• Kim HC, Kim DJ, Huh KB. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis. 2009;2:521–5.
   Google Scholar
• Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, . Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996;5:1025–9.
   Google Scholar
• Juonala M, Viikari JS, Hutri-Kahonen N, Pietikainen M, Jokinen E, Taittonen L, . The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference. J Intern Med. 2004;4:457–68.
   Google Scholar
• Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, . Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;1:1–10.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;6:499–502.
   Google Scholar
• Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;16:1640–5.
   Google Scholar
• Koskinen J, Magnussen CG, Taittonen L, Rasanen L, Mikkila V, Laitinen T, . Arterial structure and function after recovery from the metabolic syndrome: the cardiovascular risk in Young Finns Study. Circulation. 2010;3:392–400.
   Google Scholar
• Raitakari OT, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N, . Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;17:2277–83.
   Google Scholar
• Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, . Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;2:112–7.
   Google Scholar
• Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism. 2007;6:792–8.
   Google Scholar
• Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006:S5–10.
   Google Scholar
• Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000; 17:1266–71.
   Google Scholar
• Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab. 2007;9:3490–7.
   Google Scholar
• Stranges S, Dorn JM, Muti P, Freudenheim JL, Farinaro E, Russell M, . Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology. 2004;3:754–63.
   Google Scholar
• Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963; 7285:785–9.
   Google Scholar
• Koskinen J, Kahonen M, Viikari JS, Taittonen L, Laitinen T, Ronnemaa T, . Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young Finns study. Circulation. 2009;3:229–36.
   Google Scholar
• Johnson HM, Douglas PS, Srinivasan SR, Bond MG, Tang R, Li S, . Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study. Stroke. 2007;3:900–5.
   Google Scholar
• Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol. 2005;5:1045–50.
   Google Scholar
• Pacifico L, Cantisani V, Ricci P, Osborn JF, Schiavo E, Anania C, . Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res. 2008;4:423–7.
   Google Scholar
• Schindhelm RK, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD, Heine RJ, . Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis. 2007;2:391–6.
   Google Scholar
• Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, . Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;14:2130–7.
   Google Scholar
• Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;2:235–40.
   Google Scholar
• Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data. Hepatology. 2010;3:1156–61.
   Google Scholar
• Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, . Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;6:1286–92.
   Google Scholar